• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/27

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

27 Cards in this Set

  • Front
  • Back
.antibiotic
a drugthat kills or inhibits growth of microorganism.
resistant.
antimicrobial will not inhibit bacterial growth at clinically achievable levels.
susceptible.
antimicrobial will inhibit bacterial growth at clinically achievable concentrations.
MIC
minimal inhibitory concentration. Lowest concentration of antimicrobial that inhibits growth of bacteria
MBC
Minimal bactericidal concentration. Concen of an antimicrobial that kills bacteria
breakpoint
MIC is used to designate bt susceptible and resistant
if MIC > breakpoint
resistant
if MIC < breakpoint
susceptible
reasons for antibiotic overuse
pt concern: 1)want clear explanat 2)green nasal discharge 3)need to return to work
phys concern 1)pt expects antibiotic 2)diagnostic uncertainty 3)time pressure
resistant bacteria can then be transmitted bt pts
highest risk pts: immunocompromised, hospitialized, invasive devices (central venous catheters)
give a drug X, it can become resistant to that
as well as other drugs you haven't even taken
bacteria are capable of becoming resistant thru several mechanisms, 1 or many may exist in an organism
multidrug-resistant bacteria oft en have multiple mechanisms, genes encoding resistance may exist on plasmid or chrom
B-lactamases resistance (on lots of antibiotics)
confer resistance to some, many, or all beta-lactam antibiotics; may be encoded on chromos or
more potent in gram-negative bacteria
-Examples: S. aureus, H. influenzae, N. gonorrhoeae, E. coli, Klebsiella sp. Enterobacter sp, Serratia sp.
extended spectrum beta-lactamases
-Beta lactamases capable of hydrolysing exteended spectrum cephalosporins, penicillins, and aztreonam
-most often associated w E. coli and Klebsiella pneumoniae but spreading to other bacteria
-usually plasmid mediated
-aminoglycoside,ciprofloxacin, and trimethoprim-sulfamethoxazole resistance often encoded on same plasmid
-has become a signif resistance determinate in acute and longterm care facility enteric pathogens
Class A Carbapenemases
-most common is Klebsiella pneumoniae (KPC)
-also seen in E. coli, Enterobacter, Citrobacter, Salmonella, Serratia, Pseudomonas and Proteus spp.
-very often w multiple other drug resistance mechanisms, resistance profile similar to ESBL but also carbapenem resistant
-became prob in NYC and is being increasingly recognized in MIdAtlantic US
-spreading across species to other gramnegatives and enterobacteriaceae
-emerging in long tem care facilities
Mech of Resistance: Decreased Permeability (changes this so not recognized)
Pseudomonas spp.;;;; affects many antibiotics including carbapenems
Mech of Resist: Efflux Pumbs (changes this so not recognized)
Pseudomonas spp. (multiple antibiotics), tetracylines, macrolides
Mech of Resist: Target alterat, DNA gyrase (changes this so not recognized)
-Fluoroquionolines
-many gram negatives, S. pneumoniae
Mech of Resist: Target alterat, penicillin binding protein (changes this so not recognized)
methicillin resistant S. aureus (MRSA); penicillin resistant S. pneumoniae
Mech of Resist: Target alterat, gram positive cell wall (changes this so not recognized)
vancomycin; enterococcus spp.
Mech of resist, Target Alteration, Ribosomes (changes this so not recognized)
Ribosome: Tetracyclines, Macrolides (S. pneumoniae, Staphylococcus sp., N. gonorrhoeae, enteric gram-negative rods)
Glycopeptide Resistant S. aureus: Glycopeptide Intermediate Resistance
-1st reported in Japan
-Vancomycin MIC 8ug/mL
-still uncommon
-all w/ prolonged vancomycin use due to persistent S. aureus infections (cell walls become bigger)
Glycopeptide Resistant S. aureus: Glycopeptide High Level Resistance
-Vancomycin MIC > 128 ug/ml
-diabetic w/ peripheral vascular disease and chronic renal failure
-resistance determinant acquired from Vancomycin-resistant Enterococcus
-very uncommon
resistant S. pneumoniae increasing
Resistance increases w/ antibiotic use
how is resistance most commonly transmitted in gram negative bacteria
conjugation
Communiy acquired resistant E. Coli
-mostly UTIs
-young healthy women in addit to elderly
-10 to 20 % now resist to fluoroquinolones
-30 to 50% resistant to trimethoprim-sulfamethoxazole
-CTX-M Beta-lactamases becoming more common ()cause cephalosporin resistance)
Conclusion
-inapprop and excessive use of antibiotics is a major factor contributing to emerging antibiotic resistance
-determinants of resistance are selected for by antibiotic use
- multiple mech exist for bacteria to become resist to antibiotics
-antibiotic resist is a prob in outpatient and inpat settings and is a factor in wide variety of infections
-antibiotic resist continues to emerge as serious threat to public health